Pre- and postsynaptic effects of LGI1 autoantibodies in a murine model of limbic encephalitis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Activated αβ T and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis.Brain : a journal of neurology · 2025
   Article
2. Heterogeneity of clinical features, EEG and brain imaging findings in anti-leucine-rich glioma-inactivated protein 1 autoimmune encephalitis: a retrospective case series study and review of the literature.Acta epileptologica · 2023
   Article
3. Paraneoplastic Neurologic Disorders.Current neurology and neuroscience reports · 2023
   Review
4. An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel.Cells · 2022
   Article
5. Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis.Brain communications · 2022
   Review

Corrections and comments

• Comment on
  LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.2018

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as